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SUMMARY
Background: Breast cancer patients of lower socioeconomic status tend to have poorer 
survival. This does not seem to be attributed solely to stage at presentation, but there is 
uncertainty as to the proportion of the survival deficit that is due to stage, and whether this is 
affected by the method of determining socioeconomic status. In this study, we estimate the 
extent to which the differences in survival by socioeconomic status, measured both by 
occupational and area-based methods, can be explained by differences between socioeconomic 
groups in stage and morphological type of tumour.
Method and materials: We studied survival in 10,865 cases from the East Anglian Cancer 
Registry diagnosed between 1982 and 1993.
Results: In univariate analyses, lower social class was associated with relative hazards of 1.25 
(95% Cl, 1.14-1.38) for death from all causes and 1.32 (95% Cl, 1.12-1.55) for death from 
breast cancer as underlying cause. Women resident in the most deprived area had relative 
hazards of 1.29 (95% Cl, 1.16-1.45) for death from all causes and 1.21 (95% Cl, 0.95-1.54) 
for death from breast cancer as underlying cause. Stage at diagnosis accounted for 28% of the 
effect of social class on survival to death from breast cancer. For survival to death from any 
cause, stage accounted for 63% of the effect of social class and 31% of the effect of 
deprivation category.
Discussion: The major finding is that we could not wholly or even largely account for 
socioeconomic effects on breast cancer survival by pathological factors including stage and
morphology. It is concluded that stage at presentation explains some of the socioeconomic 
differences in breast cancer survival. Future research on histological grade and socioeconomic 
status is indicated. It would be useful to confirm these findings in additional studies that 
include other individual socioeconomic indices in addition to area-based and occupational 
measures.
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CHAPTER 1
1. Introduction, Objectives and Methods
1-1. Background
Breast cancer has become a major health problem over the last 50 years, affecting as many as 
one in eight women during their lifetime (Ries, 1999; Sondick, 1994). This disease is a 
significant health problem in the industrialised western world, where it is the most common 
form of cancer among women in North America and almost all of Europe (Forbes, 1997).
Breast cancer has been the subject of extensive epidemiologic studies, which have provided 
insight into the magnitude of this problem and identified factors that place women at increased 
risk for the development of this malignancy. There is substantial variation in breast cancer 
rates in women among different countries. Over one million new cases are diagnosed in 
women worldwide every year, causing over 400,000 deaths (Forbes, 1997).
Breast cancer is the most common cancer in women in England and Wales, responsible for 
about 30 % of all female malignancies and about 20% of female cancer deaths (Swerdlow et 
al, 2001). There were 27,768 new registrations of breast cancer in 1989 (Cancer- statistics, 
1989).
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13,663 deaths were attributed to breast cancer in 1992 (OPCS, 1992). The age standardized 
incidence rate of this disease was 68.2 per 100,000 for England and Wales.
The number of new breast cancer cases was increased to 33,829 in year 2000, which was 
about 30 % of all cancers in women (Figure 1-1)
Figure 1-1. Comparison of breast cancer to other common cancers in women in UK (National 
Statistics 2000).
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Survival from breast cancer has improved gradually over time due to earlier detection of 
tumour, use of effective adjuvant therapy and, more recently, the introduction of Breast 
Screening Programme (Coleman et al, 1999; Berrino, 1995).
1-2. Socioeconomic status and cancer mortality
The effect of socioeconomic status (SES) differences in mortality has been reported for a 
variety of causes of death including cancer (Carola, 1994). Cancer mortality is generally 
higher in people of low socioeconomic status compared with those of higher socioeconomic 
status (Kogevinas et al, 1991). This mortality penalty may be due to differences in cancer 
incidence or cancer survival. Socioeconomic status (SES) can be considered as a “cross­
cutting risk factor”, which means that it may be simultaneously related to incidence by the risk 
for developing cancer, as well as to survival from the disease (Baquet et al 2000).
Understanding socioeconomic differences in cancer incidence and cancer survival is not only 
of academic interest; such information is required to design health policy measures. 
Differences in cancer incidence demand intervention in the area of primary prevention, 
whereas socioeconomic differences in cancer survival demand policy measures in the area of 
secondary prevention or treatment (Carola 1994).
Socioeconomic differences in cancer survival, if not an artefact, may be related to differences 
in timing of diagnosis, in treatments applied, in biological characteristics of the neoplasm or in
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host factors, including comorbidity (Vagero & Persson, 1987). Several studies from different 
countries, based on mortality and morbidity data have shown that survival from cancer is 
associated with socioeconomic position or social class (Vagero & Persson, 1987; Camon et al, 
1994; McLoad et al, 2000; Schrijvers et al, 1995; Karjalanen et al, 1990).
In a survival analysis, Garvican et al (1998) found breast tumours in deprived women were 
more likely to have positive node status, suggesting that the relationship between deprivation 
and prognosis is due to more advanced stage at presentation in more deprived patients. Vagero 
& Persson (1987) studied the effect of socioeconomic status according to patient’s occupation 
by using the Swedish cancer registry data, finding a clear difference in relative survival for 
breast cancer. The pattern showed better survival for those with higher socioeconomic status. 
Baquet et al (2000) found that people with lower income had a death rate double that observed 
in people with income above the poverty level. These results suggested that inequalities in 
mortality and survival may be related to health care access and insurance status, income, 
educational status, health care seeking behaviour, diagnosis and treatment quality.
1-3. Breast cancer survival and deprivation based on area of residence
Research on the relationship between mortality and deprivation, based on area of residence has 
showed a strong association with several health outcomes, including cancer (Taylor et al, 
1997).
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A number of studies have analysed differences in the incidence and survival for various 
cancers (Kogevinas et al, 1990; Schrijvers et al, 1994). This would affect patients beyond their 
individual characteristics, stressing the importance of indicators and targets to monitor 
improvements around geographical areas. This approach considers patients not only as 
individuals, but also as individuals related to their environment, whose inequalities might have 
health repercussions (Carstairs, 1989). Deprivation indexes may potentially be used as a 
surrogate for health inequalities, as well as for those social conditions likely to affect survival.
Using the area of residence as a measure of deprivation has been justified on theoretical 
grounds as it has been correlated with a range of health measures, including incidence and 
mortality (Scottish Office, 1998; Townsend, 1986). The indices of deprivation according to 
area of residence can be designed using a range of small area statistics accessible from 
routinely collected census data (Jarman, 1983). The analysis of health data based on area of 
residence is feasible due to the use of postcodes, which accompany most health related data 
(Harris et al, 1998). The ease with which the data are accessed reduces substantially the costs 
of the analysis if compared to those studies where further data collection is required.
1-4. Breast cancer survival and social class based on occupation
Studies of social class and health show poorer health and shorter life expectancy in general for 
the deprived people. The degree of the difference, however, varies with the measures
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used and the social group being studied. Furthermore, the social class indicator used 
influences the results. Social class is defined in the UK by subject’s occupation or occupation 
of the subject’s spouse.
Differences in mortality related to social class have been reported for several diseases, 
including tumours. Stage at diagnosis has been shown to be an important factor contributing to 
social class differences in cancer survival. Nevertheless, the importance of stage seems to vary 
by type of tumour and by country. Also, definitions are hard to standardize. For instance, the 
meaning of the terms “class” or “social class” are complex. So far, to add accuracy, 
“occupational class” term has been used in European public health surveillance and research. 
The British Registrar General’s social class schema is the longest employed of these measures, 
developed by the Registrar General THC Stevenson in 1913. This approach conceptualized 
occupations as a measure of what was termed “standing within the community” or “culture”. 
This representation has proven to be predictive of inequalities in morbidity and mortality. It 
comprises five categories, as follows:
Social class I (professional), II (intermediate), IIINM (skilled non-manual), HIM (skilled 
manual), IV (partly skilled), and V (unskilled). In this sense, distinctions between different 
social classes levels are based on a graded hierarchy of occupations ranked according to skill.
One limitation of using socioeconomic indicators based on occupation in the UK, mainly for 
breast cancer, is that women workers are concentrated into fewer and less well paid 
occupations comparing to men, in each level of the Registrar General’s social class. An 
additional liability of occupation-based measures is that they cannot readily be used for social 
groups outside of the recognized paid labour force. Among those groups, we can include 
retired adults who are unemployed and homemakers (chiefly women) who do not work
outside of home. In the past, husband’s occupation has been used to define a women’s social 
class.
1-5. Review of literature
The first study to find an association between socioeconomic status and breast cancer survival 
was conducted by Cohart in 1955. Later on, a large difference was found among ethnic groups 
in the US (Young 1981). Since then, the relationship between breast cancer and 
socioeconomic deprivation has proved to be complex and studies have so far have provided 
equivocal and inconclusive results. This is because although most studies found poorer 
survival in lower SES groups, the magnitude of the difference and the extent to which of is 
attributed to stage or other factors vary between studies. Thus, the relation between 
deprivation and breast cancer survival is not fully understood.
Affluent women have a higher incidence of breast cancer than those socially deprived. 
Regarding prognosis, several studies have shown that deprived women have poorer survival 
from breast cancer (Camon et al, 1994; Macleod et al, 2000; Schrijvers et al 1995, Karjalanen 
et al 1990).
It is possible that women of lower socioeconomic present with late stage disease because of a 
combination of decreased access to medical care and decreased awareness of the importance 
of early cancer detection. The role of ethnic differences as a possible index for socioeconomic 
status in survival from breast cancer has also been reported in the US (Young et al, 1981; 
Richardson et al, 1992; Eley et al, 1994; Hsu et al 1997; Hunter 2000). Freeman & Wasfie
(1989), in a retrospective study on disparity of breast cancer survival concluded that inequality 
in survival for poor black women compared with black women nationally, and with white 
women, was due to late stage of disease at diagnosis. They found that about 49% of poor 
black women presented their cancer with stage III and Stage IV. Therefore, they believed that 
late diagnosis was the single most important factor responsible for inequality of survival in 
their study. Also for example, Bibb et al (2000) studied the survival of patients with breast 
cancer in the US, comparing African American against white women. The results revealed that 
the late stage of breast cancer was more likely to be diagnosed in African American women 
with low socioeconomic status.
Thus, women from deprived areas or groups are less likely to get breast cancer, but experience 
poorer survival than their more affluent counterparts. The combined effect on mortality is 
usually to the detriment of the lower SES groups. The cause for this differential mortality 
experience remains uncertain. It is probably multifactorial. A number of reasons have been 
proposed, including differences in tumour stage, tumour biology, treatments or host response 
(Garvican & Littlejohns 1998).
Schrijvers et al (1995) have shown differences of 35% in survival rates in favour of affluent 
women over deprived women, for all ages. Camon et al (1994) also found significantly worse 
survival from breast cancer in socio-economically deprived groups after adjustment for stage 
of disease. Dayal et al (1982) looked at the effect of race and socioeconomic status, and found 
that both produced different survival patterns. Basset et al (1986) found that social class was a 
significant factor in determining survival after a diagnosis of breast cancer, with a relative risk 
of 1.52 (95% Cl, 1.28-1.88) for deprived as opposed to affluent women. Vagero & Persson 
(1987) also found differences in survival by social class in a study of Swedish cancer patients.
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Socioeconomic differences in breast cancer survival have been reported in studies from the 
US, Finland, Sweden, Australia, Scotland and England and Wales. Large socioeconomic 
differences in breast cancer survival have been observed in England and Wales (Coleman et al 
1999). Exceptionally, one study showed that breast cancer patients of low socioeconomic 
status had a higher (although only slightly) chance of survival from their disease than breast 
cancer patients of higher social classes (Kogevinas 1991). However, they defined high and 
low socioeconomic groups by whether the patients were homeowners or council tenants. They 
excluded those who did not fit either of these categories from their study. Another problem 
with using such a crude measure of socio-economic status is that it is likely to misclassify very 
large numbers of patients, as being deprived and council tenant status are not synonymous. For 
instance, in some areas of England there can be high levels of home ownership coupled with 
high levels of overcrowding, which on most definitions of deprivation is somewhere near the 
top of the list of indicators.
Many studies that have examined the effect of socio-economic status on breast cancer survival 
have included the age of patients as a possible confounding variable to be adjusted for in the 
analysis. For example, Dayal et al (1982) found that in 5-year survival after breast cancer, 
patients aged 40-59 had higher survival, followed by those aged over 60. Patients under 40 
had the worst prognosis. However, looking at the longer-term survival (10 years), they found 
that there was an inverse relationship between age at diagnosis and survival probabilities, 
although the differences were not statistically significant. Ansell et al (1993) also found a non­
significant relative risk of 1.06 due to adjusting for age as a confounder of socioeconomic 
status.
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The study by Camon et al (1994) also found differences in survival by age-group, with those 
aged less than 44 having the highest survival times, and those aged between 55 and 76 having 
the lowest survival. Schrijvers et al (1995) found a steeper gradient between socio-economic 
groups in the 65-99 age group than in the under 64 group, although this difference was 
accounted for when adjusting for stage of the cancer at diagnosis, the morphology of the 
cancer, and the type of treatment undertaken.
Table 1 shows the relative risk for fatality reported in different studies, according to 
socioeconomic differences.
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Table 1-1: Socio-economic differences in survival from breast cancer (Garvican & Littlejohns 
1998).
Reference, country SES by various 
measures
Relative risk (95% Cl) Comments
Auvinen, 1995 
Finland
I 0.75 (0.65-0.86) Risk ratio adjusted for age and year o f  diagnosis. Five year 
cumulative survival: class I, 77%, class II, 75%, class III, 73% Class 
IV, 72%.
II 0.85 (0.76-0.94)
III 0.93 (0.85-1.03)
IV 1.0
Bassett & Kriiger, 
1986, US
High 1.0 Relative risk adjusted for race, age, stage and histology.
Low 1.52 (1.28-1.88)
Burnett et al,1993 
Australia
High 1.0 Cox regression analysis was performed.
Low 1.35 (1.00-1.70)
Karjalainen & 
Pukkala, 1990 
Finland
I 0.78 (0.68-0.90) Risk ratio adjusted for age. Follow-up, period o f  diagnosis 
stage, and the interaction o f  stage and follow-up period.II 0.85 (0.77-0.93)
III 0.92 (0.88-0.97)
IV 1.0
LeMarchand et al. 
1984; US
High 1.0 Relative risk (95% Cl), adjusted for age, stage, race, histology and 
marital status.Medium 0.96 (0.77-1.20)
Low 1.23 (0.97-1.57)
Schrijvers et al, 
1995a, England
Affluent 1.0 Cox regression adjusted for follow-up period and period o f  
diagnosis. Women aged 30-64.2 1.15 (1.05-1.27)
3 1.30 (1.18-1.44)
4 1.31 (1.18-1.46)
Deprived 1.35 (1.16-1.57)
Schrijvers et al 
1995b,
The Netherlands
High 1.0 Cox regression adjusted for age and period o f  follow-up.
2 1.06 (0.84-1.33)
3 1.04 (0.86-1.26)
4 1.15 (0.96-1.38)
Low 1.18 (0.99-1.42)
Boffeta et al, 1993 
Italy
>or=7 year 0.70 (0.40-1.10) Relative risk adjusted for age. SES based on education.
<7 year 1
Kogevinas et al,91 
England and Wales
Owner occupier 0.99 Standardized case fatality ratio. Crude five-year survival: 50% for 
owner occupiers, and 52% for council tenants.Council tenant 0.97
Waxler-Morrison et 
al, 1991,Canada
Employed 1.0 Cox regression adjusting for nodal status, stage, marital status.
Not -employed 1.52
Rosso et al, pers. 
Commun,
Italy.
University 0.89 (0.54-1.49) Relative risk adjusted for age, place o f  birth and housing.
High 0.94 (0.70-1.27)
Middle 1.01 (0.99-1.51)
Low 1.0
Nandacumar et al 
1995; India
Illiterate 1.0 Relative risk (95% Cl), adjusting for religious group, marital status 
and clinical extent o f  the disease. Five-year survival rates were 
35%(illiterate) and 46% (literate)
Literate 0.7 (0.60-0.80)
Gordon et al., 1992 
US
High 1.00 Cox regression
Low 1.49 (1.17-1.89)
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1-6. Objective
This study is an analysis of survival data, to examine the effect, if any, of socioeconomic 
status at the time of diagnosis on survival. A univariate analysis will be performed first. 
Thereafter, a series of multivariate Cox regression models will be fitted, in which 
socioeconomic status will be adjusted for.
In particular, we were interested to see which factors caused alteration of the SES effects on 
survival when adjusted for in a multivariate model. Potential influences on survival in breast 
cancer include the stage at diagnosis, the tumour type (morphology), and histological grade. 
These could be confounded with SES in various ways, and each would be responsible to a 
greater or lesser extent for the observed poorer survival in women of low SES.
The simplest example is stage of disease at diagnosis. This is a combination of size of the 
tumour in the breast and the extent to which it has spread beyond the breast, in particular to 
the regional lymph nodes. If, for example, women of low SES were less aware of breast 
symptoms or less likely to receive mammography screening, they would have later stage at 
diagnosis, and adjustment for stage in a multivariate survival model would tend to attenuate 
the estimated effect of SES on survival. If this were the case, the target for public health would 
be education on breast symptoms and efforts to improve participation of women of lower SES 
in screening.
Morphological type of tumour is its innate structure as observed microscopically by the 
pathologist. For this study, morphology was coded as:
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Group 1: Ductal carcinoma.
Group 2: Medullary carcinoma
Group 3: Lobular carcinoma
Group 4: Mucinous & Tubular carcinoma
Group 5: Adenocarcinoma, not otherwise specified
Group 6: Other morphology
Different types of tumours are associated with different survival (Tabar et al, 1996). In 
addition, they have different risk factors (Duffy et al, 1999). Due to differences in risk factor 
prevalences or to genetic effects, low SES women might be more prone to the more severe 
morphological types. This would be manifested in a reduction in the effect of SES after 
adjustment for type. Such a phenomenon would suggest that measures aimed at primary 
prevention and better access to treatment would be the appropriate public health targets.
Histological grade is a combination of microscopic measurements, scored 1-3 with 1 
representing good prognosis, 2 intermediate and 3 poor. It has in the past been thought to be 
innate and unchanging within the tumour although there is now evidence that it deteriorates as 
the tumour grows (Tabar et al 1996).Thus if grade were responsible for the effect of SES, a 
combination of measures aimed at prevention, screening and treatment would be indicated as 
targets for public health.
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1-7. Survival time calculation
In the primary survival analysis we used only those tumours diagnosed in 1982-1993. This 
was because prior to 1982, the data on stage, morphology etc was usually not available. We 
used data on cases prior to 1994 because for these subjects tumour data and follow up to the 
end of 1998 were considered to be complete.
Survival time was calculated as the time difference, in years, between date of diagnosis and 
date of death or December 31, 1998, for those who did not die during the follow-up period. 
Date of diagnosis used to calculate survival time was that obtained from chart review. For the 
analysis of breast cancer only deaths, patients dying of causes other than breast cancer were 
censored on their date of death.
1-8. Measures of SES used
In this study, the simple index of Carstairs and Morris (1989) was used. It is based on the 
categorisation of the 1991 census-derived deprivation score at enumeration districts level 
(Pollock 1997). In order to estimate the socio-economic status of the patients, a surrogate 
measure is used, due to the difficulties in classifying women by occupation. As an example of 
such difficulties, Carstairs and Morris (1989) reported that in the 1981 census, 42% of women 
aged 16-64 were not assigned to an occupation on their own account.
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The Carstairs and Morris deprivation index uses the following four variables, defined as 
follows:
“Overcrowding” : The persons in private households living at a density of more than one 
person per room.
“Male unemployment”: The proportion of economically active males who are seeking a job. 
“Low social class”: The proportion of all persons in private households with head of 
household in social class 4 or 5.
“No Car”: The proportion of all persons in private households with no car.
Each of these variables are summed for a small geographical area based on census 
enumeration districts, having first been standardised by subtracting the mean for Great Britain 
as a whole, and dividing by the population standard deviation. All the Carstairs scores are then 
ranked for the whole of Great Britain. Each census enumeration district was then assigned a 
deprivation category, from 1 (affluent) to 5 (deprived). The deprivation score for each woman 
then was found by linking the postcode of her home to the corresponding census enumeration 
index, as described by Schrijvers et al (1995).
1-9. Descriptive analysis
Before detailed survival analysis, statistics were generated to compare the characteristics of 
women who were categorised in different socioeconomic levels. The relationship of each 
covariate to socioeconomic status was examined by tabulation, and likelihood ratio chi- 
squared statistics were calculated to assess whether differences in proportion between the 
exposure groups could be attributed to random variation.
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The relationship of each covariate to the outcome of interest (survival) was examined by 
modelling each variable individually, adjusted and unadjusted, using Cox’s proportional 
hazards model. Survival estimates were obtained using the Kaplan-Meier estimate.
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CHAPTER 2
2. Data available
2-1. Introduction
In this chapter, the data source and explanatory variables will be introduced, as well as the 
manner in which the variables were coded to ease the analysis. The rationale used to decide 
which variables were studied will also be explained. This thesis is intended to cover the major 
prognostic factors stage at presentation, grade and morphology of tumour, which might 
contribute to socio-economic differences in breast cancer survival.
2-2. East Anglian Cancer Registry (EACR)
This study uses data from the East Anglian Cancer Registry (EACR). The EACR was 
established in 1989 by the union of registries in Cambridge, Norwich and Ipswich. The 
registry holds computerised information since 1971, on cancers diagnosed in residents of 
Cambridgeshire, Norfolk and Suffolk, which have a combined population of approximately 
two million (population estimates unit, 1991:OPCS).
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Information is sought by the EACR from a variety of sources including pathology laboratories, 
death certificates, hospital information systems, general practitioners, medical records, post 
mortem reports, and radiotherapy units. The registry is located in Cambridge with satellite 
bureaux in Norwich and Ipswich.
The EACR is the only UK registry with a system of “active follow up”. Vital status is sought 
on patients at three years and at subsequent five-year intervals until death. This has the 
advantage of providing several opportunities to collect data that may be unavailable at initial 
registration. The current data-set includes all items on the National Minimum Data-set, vital 
status at follow up, and causes of death.
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2-3. Breast cancer by year
For this study, data were available on cases diagnosed in four major hospitals in the East 
Anglian region. These hospitals were Addenbrooke’s, Norfolk & Norwich, Ipswich and West 
Suffolk. Between 1982 and 1993 a total of 10865 breast cancer cases were diagnosed in these 
hospitals. The number of cases in different years between 1982 and 1993 is shown in table 2- 
1. This table shows that the number of breast cancers increased gradually over the years of 
study.
Table 2-1. Distribution of breast cancer by year of diagnosis in 
four major hospitals, in the East Anglian Region, 1982-1993.
Year No of cases Percent Cumulative (%)
1982 701 6.4 6.4
1983 754 7.0 13.4
1984 733 6.7 20.1
1985 828 7.6 27.7
1986 823 7.6 35.3
1987 959 8.8 44.1
1988 966 8.9 53.0
1989 999 9.2 62.2
1990 922 8.5 70.7
1991 997 9.2 79.9
1992 1051 9.7 89.6
1993 1132 10.4 100.0
Total 10865 100.0 100.0
21
2-4. Breast cancer by stage
Table 2-2 demonstrates the distribution of stage at the time of presentation in women with 
breast cancer in this study. About 9% of the patients did not have stage recorded.
Table 2-2. Distribution of stage in women with breast cancer 
diagnosed between 1982 and 1993.
Stage Frequency Percent
1 3469 31.9
2 4230 38.9
3 1504 13.9
4 698 6.4
Unknown 964 8.9
Total 10865 100.0
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2-5. Breast cancer by grade
Table 2-3 shows the cases by histological grade. As the overwhelming majority had grade 
unrecorded, this was omitted from the primary survival analysis, but see chapter 5.
Table 2-3: Distribution of grade in women with breast cancer, diagnosed in 
East Anglian Cancer Registry between 1982 and 1993.
Grade Frequency Percent
1 293 2.6
2 665 6.1
3 615 5.7
Unknown 9292 85.6
Total 10865 100.0
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2-6. Breast cancer by morphology
Breast cancer classified by morphological type is shown in table 2-4.
This variable is of limited use since 16% are classified as adenocarcinoma not otherwise 
specified, and 27% as “others”. Since most tumour series comprise of 70-80% ductal 
carcinoma, we might speculate that the majority of adenocarcinoma and others are of ductal 
type, but we cannot be certain.
Table 2-4: Frequency of morphology in women with breast cancer, 
diagnosed between 1982-1993
Morphology Frequency Percent
Ductal 4454 41.0
Medulary 154 1.4
Lobular 1314 12.0
Mucinus & Tubular 298 2.8
Adenocarcinoma 1716 15.8
Others 2929 27.0
Total 10865 100.0
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2-7. Breast cancer by age group
The patients were grouped into five categories of age at diagnosis which are shown in table 2- 
5. As expected, the older age groups dominate, and breast cancer diagnosed under age 40 was 
rare.
Table 2-5: Distribution of women with breast cancer by different group 
of age, diagnosed between 1982-1993
Age group Frequency Percent
<40 635 5.8
40-49 1767 16.3
50-59 2211 20.3
60-69 2743 25.3
>70 3509 32.3
Total 10865 100.0
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2-8. Breast cancer by social class
Table 2-6 shows the frequency of social class based on patient occupation in the present study. 
More than 61% of patients in the database had no information on occupation. For this reason, 
social class was dichotomised to non-manual (I-II-IIIN) and manual (IIIM-IV-V) in analyses 
below.
Table 2-6: Distribution of social class in women with breast cancer, 
diagnosed between 1982 and 1993.
Occupation Frequency Percent
I 59 0.5
II 1106 10.2
IIIN 1823 16.8
HIM 294 2.7
IV 567 5.2
V 295 2.7
Not known 6721 61.9
Total 10865 100.0
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2-9. Breast cancer by deprivation
Table 2-7: Distribution of deprivation category in women with breast cancer 
diagnosed between 1982 and 1993.
Deprivation Frequency Percent
1 (Affluent) 2529 23.3
2 2983 27.4
3 2788 25.7
4 1904 17.5
5 (deprived) 661 6.1
Total 10865 100.0
Table 2-7 shows the cases subdivided by deprivation category, as determined by area of 
residence using the Carstairs index (Carstairs and Morris, 1989). Note that this is complete for 
all subjects, since all that is required to categorise a subject is her postcode of residence.
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2-10. Breast cancer by hospital
Table 2-8: Distribution of breast cancer in four major hospitals in 
East Anglia Region, 1982-1993.
Hospital Frequency Percent
Addenbrooke’s 5301 48.8
Norfolk & Norwich 3147 29.0
Ipswich 2097 19.2
West Suffolk 320 3.0
Total 10865 100.0
Table 2-8 shows the hospital of diagnosis for the 10865 cases. The majority were diagnosed in 
the two large general hospitals, Addenbrooke’s hospital, Cambridge and the Norfolk and 
Norwich hospital.
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2-11. vital status and prognostic variables
Here we tabulate the major variables of interest by whether the subject was alive or dead (from 
any cause) at follow up. This is not for purposes of formal inference, but to describe the basic 
data available for analysis. Formal inference about the effects of the various factors on 
survival will take into account time to death, and will be presented in chapter 4.
Table 2-9 shows deprivation category by vital status. Table 2-10 shows the corresponding 
table for social class. Both support an association of death with lower SES.
Table 2-9: Frequency of breast cancer diagnosed between 1982 and 1993, by Carstairs 
deprivation index and vital status.
Carstairs deprivation index
Frequency 
No. % No.
Alive
%
Died
No. %
1 (Affluent) 2529 23.3 1133 44.80 1396 55.20
2 2983 27.4 1280 42.90 1703 57.10
3 2788 25.7 1148 41.17 1640 58.83
4 1904 17.5 773 40.59 1131 59.41
5 (deprived) 661 6.1 242 36.61 419 63.39
Total 10865 (100) 4576 42.11 6289 57.89
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Table 2-10: Frequency of social class in women with breast cancer by vital status, diagnosed
between 1982 and 1993.
Social class
No.
Total
%
Alive
No. %
Died
No. %
High 2988 72.10 1559 52.17 1429 44.83
Low 1156 27.90 450 38.92 706 61.08
Total 4144 100 2009 48.47 2135 51.53
Table 2-11 shows vital status by morphology. There appears to be a positive association of the 
adenocarcinoma and “others” categories with death. Table 2-12 shows vital status by age at 
diagnosis, showing as one might expect a positive correlation of death with older age.
Table 2-13 shows vital status by stage, with deaths tending to occur in the more advanced 
stage, as expected. The corresponding data for histological grade are shown in table 2-14, with 
an association of grade 3 with a higher proportion of deaths.
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Table 2-11: Frequency of morphology of breast cancer by vital status, diagnosed between
1982-1993
Morphology
No
Total
% No
Alive
% No
Died
%
Ductal 4454 40.99 2418 54.28 2036 45.72
Medulary 154 1.41 90 58.44 64 41.56
Lobular 1314 12.09 642 48.55 672 51.15
Mucinos/Tubular 298 2.74 203 68.12 95 31.88
Adenocarcinoma 1716 15.79 627 36.53 1089 63.47
Others 2929 26.95 596 20.34 2333 79.66
Total 10865 100.00 4576 42.11 6289 57.89
Table 2-12: Frequency of patients by age showing the total in each age-group, concerning the 
number of dead and alive.
Age group Total
No. %
Alive
No. %
Died
No. %
<40 635 5.84 326 51.33 309 48.67
40-49 1767 16.24 1028 58.17 739 41.83
50-59 2211 20.35 1270 57.44 941 42.56
60-69 2742 25.24 1287 46.93 1456 53.07
+70 3509 32.30 665 18.95 2844 81.05
Total 10865 100 4576 42.11 6289 57.89
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Table 2-13: Vital status by stage in women with breast cancer- diagnosed between 1982 and
1993.
Stage Total
No % No
Alive
% No
Died
%
1 3469 23.74 2351 67.77 1118 32.23
2 4230 18.74 1856 43.87 2365 56.13
3 1504 2.44 242 16.09 1262 83.91
4 689 0.28 28 4.06 670 95.94
Total 9901 100 4486 45.30 5415 54.70
Table 2-14: Frequency of grade in women with breast cancer by vital status, diagnosed 
between 1982-1993
Grade No
Total
%
Alive
No % No
Died
%
1 293 18.63 242 82.54 51 17.41
2 665 42.28 432 64.96 233 35.04
3 615 39.10 335 54.47 280 45.53
Total 1573 100.00 1009 64.14 564 35.86
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2-12. Variables used in survival analysis
The major variables for survival analysis are age, social class (non-manual and manual), 
deprivation (5 categories), disease stage and morphological type. Due to the small number 
with known grade, this will not be part of the main survival analysis, although we shall 
consider it in detail in chapter 5. The major target of the analysis is to estimate the extent to 
which stage and morphology account for the effect of social class and deprivation.
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CHAPTER 3
3. Relationship between socioeconomic status and other 
variables
3-1. Introduction
In this chapter, the joint distribution of the 10865 women with breast cancer diagnosed 
between 1982 and 1993, by SES and tumour attributes will be examined. This will establish 
for example, whether or not women with low SES present with tumours at a more advanced 
stage.
3-2. Social class
Table 3-1 shows the cross-tabulation of disease stage and social class. Women in the low 
(manual) social class tend to have worse stage at presentation. This is statistically significant 
(pO.OOl).
Table 3-2 shows the distribution of histological grade by social class. Although there are 
higher proportions of low social class women with grade 2 and 3, this does not reach statistical 
significance. It should be noted, however, that less than 10% of the cases have grade recorded.
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Table 3-3 shows the cross-tabulation of morphology by social class. The lower social class 
women have slightly lower rates of ductal carcinoma and slightly higher rates of 
adenocarcinoma not otherwise specified and “others” (p<0.001). This may be due to treatment 
in centres with less specialised pathology laboratories rather than a biological effect.
Table 3-4 shows social class by age at diagnosis. The low social class cases are slightly older, 
but this is not significant. Table 3-5 shows social class by hospital. A greater proportion of 
lower social class women was observed in the Norfolk and Norwich and Ipswich hospitals, but 
this was not significant.
Table 3-1: Distribution of stage by social class in women with breast cancer, diagnosed 
between 1982 and 1993.
Stage
Social class
High Low Total
No (%) No (%) No (%)
1 1156 (40.2) 377 (34.4) 1533 (38.6)
2 1257 (43.8) 468 (42.7) 1725 (43.5)
3 302 (10.5) 163 (14.9) 465 (11.7)
4 157 (5.5) 87 (7.9) 244 (6.2)
Total 2872 (100) 1095 (100) 3967 (100)
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Table 3-2: Distribution of grade by social class in women with breast cancer, diagnosed
between 1982 and 1993, EACR.
Social class
Grade
High Low Total
No (%) No (%) No (%)
1 117 (18.6) 26 (12.4) 143 (17.1)
2 262 (41.7) 91 (43.6) 353 (42.1)
3 250 (39.7) 92 (44.0) 342 (40.8)
Total 629 (100.0) 209 (100.0) 838 (100.0)
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Table 3-3: Distribution of morphology by social class in women with breast cancer,
diagnosed between 1982 and 1993, EACR
Morphology
Social class
Total
High Low
No (%) No (%) No (%)
Ductal 1524 (51.0) 525 (45.4) 2049 (49.4)
Medulary 52 (1.7) 21 (1.8) 73 (1.8)
Mucinus & Tubular 411 (13.8) 136 (11.8) 547 (13.2)
Lobular 87 (2.9) 29 (2.5) 116 (2.8)
Adenocarcinoma 400 (13.4) 165 (14.3) 565 (13-6)
Others 514 (17.2) 280 (24.2) 794 (19.2)
Total 2988 (100) 1156 (100) 4144 (100)
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Table 3-4: Distribution of age group by social class in women with breast cancer, diagnosed
between 1982 and 1993, EACR.
Age group
Social class
TotalHigh Low
No (%) No (%) No (%)
<40 249 (8.3) 86 (7.4) 335 (8.1)
40-49 732 (24.5) 263 (22.8) 995 (24.0)
50-59 759 (25.4) 296 (25.6) 1055 (25.4)
60-69 691 (23.1) 256 (22.2) 947 (22.9)
+70 557 (18.7) 255 (22.0) 812 (19.6)
Total 2988 (100.0) 1156 (100.0) 4144 (100.0)
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Table 3-5: Distribution of social class by hospital in women with breast cancer
diagnosed between 1982 and 1993.
Social
class
Hospital
Addenbrooke’s Norfolk/Norwich Ipswich West Suffolk Total
No (%) No (%) No (%) No (%) No (%)
High 1802 (73) 698 (71) 419 (70) 69 (77) 2988 (72)
Low 661 (27) 291 (29) 183 (30) 21 (23) 1156 (28)
Total 2463 (100) 989 (100) 602 (100) 90 (100) 4144 (100)
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3-3. Deprivation
Table 3-6: Distribution of stage by deprivation in women with breast cancer
diagnosed between 1982 and 1993.
Stage
Deprivation
Total1 (Affluent) 2 3 4 5 (Deprived)
No (%) No (%) No (%) No (%) No (%) No (%)
1 856 (36.9) 962 (35.3) 863 (34.4) 587 (33.8) 201 (33.3) 3469 (35.0)
2 988 (42.7) 1173 (43.0) 1066 (42.4) 750 (43.1) 253 (42.0) 4230 (42.7)
3 345 (14.7) 406 (14.9) 396 (15.8) 270 (15.5) 87 (14.4) 1504 (15.2)
4 132 (5.7) 186 (6.8) 186 (7.4) 132 (7.6) 62 (10.3) 698 (7.1)
Total 2321 (100) 2727 (100) 2511 (100) 1739(100) 603 (100) 9901 (100)
Table 3-6 shows deprivation category by disease stage. The more deprived categories are more 
likely to present with stage 3 or 4 tumours (p=0.048). The corresponding tabulation for 
histological grade is shown in table 3-7. There is a slight tendency to a small proportion of 
grade 1 tumours in the most deprived category, but this is not significant. Again, however, 
there are relatively few cases with grade recorded (14%).
Table 3-8 shows deprivation by morphological type. The more deprived categories tend to 
have lower proportions of ductal carcinoma and higher proportions of adenocarcinoma and 
“others” (p<0.001).This may reflect centre of diagnosis or treatment.
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Table 3-9 shows deprivation category by age at diagnosis. There was a significant association 
(p<0.001) with the more affluent cases tending to be younger.
Table 3-10 shows deprivation category by hospital. There was a significant association, with 
the small West Suffolk hospital having a higher proportion of more deprived women.
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Table 3-7: Distribution of grade by deprivation in women with breast cancer
diagnosed between 1982 and 1993.
Deprivation
Grade
1 (affluent) 2 3 4 5(deprived) Total
No (%) No (%) No (%) No (%) No (%) No (%)
1 72 (19.1) 82 (19.0) 69 (18.5) 55 (18.5) 15 (16.1) 293 (18.6)
2 140 (37.0) 195 (45.3) 164 (44.0) 129 (43.3) 37 (39.8) 665 (42.3)
3 166 (43.9) 154 (35.7) 140 (37.5) 114(38.2) 41 (44.1) 615 (39.1)
Total 378 (100) 431 (100) 373 (100) 298 (100) 93 (100) 1573 (100)
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Table 3-8: Distribution of morphology by deprivation in women with breast cancer diagnosed
between 1982 and 1993, EACR.
Morphology
Deprivation
Total1 (affluent) 2 3 4 5 (deprived)
No (%) No (%) No (%) No (%) No (%) No (%)
Ductal 1121 (44.3) 1237(41.5) 1087 (39.0) 762 (40.0) 247 (37.4) 4454 (41.0)
Medulaiy 42 (1.2) 37 (1.2) 34 (1.2) 32 (1.7) 9 (1.4) 154 (1.4)
Lobular 320 (12.6) 352 (11.8) 319 (11.4) 241 (12.7) 82 (12.4) 1314 (12.1)
Mucinus/ Tubular 67 (2.6) 82 (2.7) 66 (2.4) 68 (3.6) 15 (2.3) 298 (2.7)
Adenocarcinoma 361 (14.3) 469 (15.7) 464 (16.6) 299 (15.7) 123 (18.6) 1716 (15.8)
Others 618 (24.4) 806 (27.0) 818 (29.3) 502 (26.4) 185 (28.0) 2929 (27.0)
Total 2529 2983 2788 1904 661 10865 (100)
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Table 3-9: Distribution of Age group by deprivation in women with breast cancer
diagnosed between 1982 and 1993.
Age
group
Deprivation
Total
1 (Affluent) 2 3 4 5 (Deprived)
No % No % No % No % No % No %
<40 179 (7) 170 (6) 166 (6) 85 (4) 35 (5) 635 (6)
40-49 454 (18) 519 (17) 424 (15) 284 (15) 86 (13) 1767 (16)
50-59 545 (22) 576 (19) 545 (20) 395 (21) 150 (23) 2211 (20)
60-69 610 (24) 761 (26) 717 (26) 463 (24) 192 (29) 2743 (25)
+70 741 (29) 957 (32) 936 (33) 677 (36) 198 (30) 3509 (33)
Total 2529 (100) 2983 (100) 2788 (100) 1904 (100) 661 (100) 10865 (100)
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Table 3-10: Distribution of deprivation by hospital in women with breast cancer diagnosed
between 1982 and 1993.
Hospital
Deprivation Addenbrooke’s Norfolk/Norwich Ipswich West Suffolk Total
No (%) No (%) No (%) No (%) No (%)
1 (Affluent) 1268 (24) 677 (21) 516(27) 68 (21) 2529 (23)
2 1385 (26) 947 (30) 561 (27) 90 (8) 2983 (27)
3 1330 (25) 806 (26) 571 (27) 81 (25) 2788 (26)
4 971 (18) 534 (17) 328 (16) 71 (22) 1904 (18)
5 (Deprived) 347 (7) 183 (6) 121 (3) 10(4) 661 (6)
Total 5301 (100) 3147 (100) 2097(100) 320 (100) 10865 (100)
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3-4. Analysis of the two indices of SES
Table 3-11 shows social class tabulated by deprivation category. As one would expect, there is 
a clear and strong relationship between the two factors (p<0.001). In the most affluent 
category, only 18% were in the lower social class, whereas 49% of the most deprived were in 
the lower social class.
Table 3-11: Distribution of social class by deprivation in women with breast cancer 
diagnosed between 1982 and 1993.
Social
class
Deprivation
Total1 (Affluent) 2 3 4 5 (Deprived)
No (%) No (%) No (%) No (%) No (%) No (%)
High 852 (82.2) 842 (76.0) 708 (69.3) 448 (63.4) 138 (51.0) 2988 (72.1)
Low 185 (17.8) 265 (24.0) 314 (30.7) 259 (36.6) 133 (49.0) 1156 (27.9)
Total 1037 (100) 1107 (100) 1022 (100) 707 (100.0) 271 (100.0) 4144 (100)
3-5. Discussion
Arguably the most important results in this chapter relate to the significant associations of 
disease stage with social class and disease stage with deprivation category. For either measure, 
low socioeconomic status was significantly associated with more advanced stage of breast 
cancer at presentation. This suggests that at least some of the poorer survival of low 
socioeconomic status breast cancer patients, which has been observed in the past, may be
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attributable to later diagnosis and therefore poorer stage. The joint effects on survival will be 
examined in the next chapter. There were also significant associations of morphological type 
with social class and with deprivation category, but these were mainly due to more tumours in 
the low socioeconomic status cases falling into the less specific categories (adenocarcinoma 
not otherwise specified and ‘other’), rather than to particular types associated with poorer 
prognosis.
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CHAPTER 4
4. Survival Analysis (excluding grade)
4-1. Introduction
This chapter gives the main results of this thesis. We report the effects of social class and 
deprivation category on survival, both for breast cancer deaths and for all causes. We give the 
estimates both unadjusted and adjusted for stage and morphology, to show the extent to which 
the effect of socioeconomic status on survival can be attributed to stage at diagnosis on type of 
tumour. The degree to which the socioeconomic effects can be attributed to stage or 
morphology is quantified using the estimate of Freedman et al (1992) as follows: if HRu is the 
hazard ratio for social class adjusted only for age and HRa is the hazard ratio adjusted for both 
age and stage, the percentage of the age-adjusted social class effect which is attributable to 
confounding with stage is
1 log (HRh) I
Thus, if the adjusted and unadjusted hazard ratios were exactly equal (i.e. adjusting for stage 
made no difference to the estimate at all), then the percentage attributable would be 0%. If on
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the other hand, the adjusted hazard ratio was 1.0 (i.e., no effect of social class whatever after 
adjusting for stage), the estimate would be 100% of the effect attributable to stage.
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4-2. Univariate and age-adjusted analysis
In this section we report univariate analyses. In order to examine the crude effects of each 
individual risk factor, we show survival curves using Kaplan-Meier survival estimates. We 
also show age-adjusted relative hazards from proportional hazards regression modelling.
Table 4-1 allows a first glance at the data, in terms of age-adjusted relative hazard estimates of 
breast cancer death for the main explanatory variables and of simple 5-year survival 
probability comparisons. For each category of each of five explanatory variables, the table 
reports the total number of cases in the category (column 3), the number of cases in this 
category who died of breast cancer (column 4), the 5-year survival probability with 
corresponding 95% confidence interval (columns 5-6), and the estimated age-adjusted hazard 
ratio and its corresponding 95% confidence interval. A separate proportional hazards analysis 
was performed for each of the five variables to estimate the hazard ratios for the 
corresponding categories. The analysis did not acknowledge the ordinal nature of the variables 
stage, grade and deprivation, as these variables were treated as categorical factors. Table 4-2 
shows the corresponding results for deaths from all causes among breast cancer cases.
Survival curves (breast cancer deaths only) for deprivation category, social class and stage are 
shown in Figures 4-1 to 4-3. Interestingly, for deprivation category, the differences in survival 
only emerge after around six years, suggesting a possible treatment effect.
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Figure 4-1: Survival (breast cancer deaths only, x-axis is in days) by deprivation category
Kaplan-Meier survival estimates, by depcat
2000 4000 
analysis time
6000 8000
depcat = 1   depcat = 2
depcat = 3   depcat = 4
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4-2: Survival (breast cancer deaths only, x-axis is in days) by social class
Kaplan-Meier survival estimates, by soc
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analysis time
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soc = 0   soc = 1
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Figure 4-3: Survival (breast cancer deaths only, x-axis is in days) by stage at presentation
Kaplan-Meier survival estimates, by stage
o 2000 4000 6000 8000
analysis time
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Table 4-1: Basic data and age-adjusted estimates of survival effects by univariate analysis
(breast cancer deaths only)
Factors Category No. of 
cases
No. of 
deathsa
5-year
survival
probability
(95% C l ) Haz.
Ratio
(95% Cl)
1 3469 260 0.96 0.95-0.97 1.00 . . .
Stage 2 4230 651 0.91 0.89-0.92 2.40 2.07-2.78
3 1504 237 0.89 0.81-0.87 3.56 2.97-4.26
4 698 142 0.62 0.55-0.69 11.31 9.17-13.93
Grade 1 293 12 0.98 0.94-0.99 1.00 ___
2 665 103 0.89 0.85-0.91 4.08 2.24-7.42
3 615 169 0.79 0.75-0.83 7.27 4.04-13.08
Morphology Ductal 4454 605 0.90 0.89-0.92 1.00 —
Medulary 154 15 0.93 0.86-0.97 0.63 0.37-1.05
Lobular 1314 205 0.91 0.89-0.93 1.12 0.95-1.31
Mucinus/tubular 298 15 0.99 0.96-1.00 0.30 0.18-0.52
Adenocarcinoma 1716 186 0.95 0.93-0.97 0.67 0.56-0.79
Others 2929 357 0.88 0.86-0.90 1.08 0.94-1.25
Social class High 2988 448 0.90 0.88-0.91 1.00 . . .
Low 1156 240 0.86 0.83-0.88 1.32 1.12-1.55
Deprivation Most affluent 2529 320 0.91 0.89-0.92 1.00 —
2 2983 376 0.91 0.90-0.93 1.01 0.87-1.18
3 2788 357 0.91 0.89-0.93 1.02 0.87-1.19
4 1904 240 0.91 0.89-0.93 1.00 0.84-1.18
Most deprived 661 90 0.91 0.88-0.94 1.21 0.95-1.54
a Underlying cause.
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Table 4-2: Basic data and age-adjusted estimates of survival effects by univariate analysis for
all causes of deaths.
Factors Category No. of 
cases
No. of 
deaths a
5-year
survival
probability
(95% C l ) Haz.
Ratio
(95% Cl)
1 3469 530 0.84 0.83-0.86 1.00 . . .
Stage 2 4230 1370 0.67 0.65-0.69 2.05 1.91-2.21
3 1504 933 0.37 0.35-0.41 4.52 4.17-4.91
4 698 606 0.13 0.10-0.16 11.40 10.34-12.57
Grade 1 293 20 0.92 0.89-0.96 1.00 —
2 665 130 0.79 0.76-0.83 2.15 1.59-2.92
3 615 174 0.71 0.67-0.75 2.62 1.94-3.54
Morphology Ductal 4454 1281 0.70 0.69-0.73 1.00 —
Medulary 154 33 0.71 0.63-0.78 0.80 0.63-1.04
Lobular 1314 376 0.71 0.68-0.74 1.11 1.02-1.22
Mucinus/tubular 298 36 0.87 0.83-0.91 0.59 0.48-0.74
Adenocarcinoma 1716 645 0.62 0.59-0.65 1.31 1.22-1.42
Others 2929 1724 0.40 0.39-0.43 2.34 2.20-2.49
Social class High 2988 892 0.69 0.68-0.72 1.00 ™
Low 1156 409 0.64 0.61-0.68 1.20 1.09-1.32
Deprivation Most affluent 2529 906 0.63 0.61-0.66 1.00 —
2 2983 1117 0.62 0.60-0.64 1.06 0.99-1.15
3 2788 1067 0.61 0.59-0.64 1.10 1.02-1.19
4 1904 729 0.61 0.59-0.64 1.10 1.02-1.20
Most deprived 661 286 0.56 0.52-0.61 1.24 1.11-1.39
aAll causes.
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Note that in Tables 4-1 and 4-2 significant and clinically important effects are associated with 
advanced tumour stage. In particular, the 11.3 and 11.4 estimates for the hazard ratio 
associated with stage 4 shows, as expecting that a patient from the population of stage 4 cases 
is expected to have a more than 10-fold risk of dying of breast cancer or other causes when 
compared with that of a woman from the stage 1 cases. The results in these tables also support 
the hypothesis of a significant effect of grade upon hazard of breast cancer death. The 
estimated hazard ratios for the morphology variable for breast cancer deaths only indicate 
poorest survival for ductal, lobular and “others” types. For deaths from any cause, the results 
suggest an increased hazard associated with the “others” category and a moderate but 
significant increased associated with adenocarcinoma. There is also significant evidence of a 
risk decrease associated with mucinus/tubular morphology for breast cancer death and all 
causes deaths.
The estimated hazard ratios for social class are 1.32 and 1.20 for breast cancer and all causes 
deaths respectively, both significant. This suggests that a patient of low socioeconomic status 
will have a risk of dying during the follow-up period which is 20-32% higher than a patient of 
high socioeconomic status. Of all the categories of deprivation, only the most deprived one 
appears to be associated with a statistically significant or suggestive effect on fatality.
The initial main question addressed by this project is the extent to which the significant effects 
associated in a univariate analysis with deprivation and social class are attributable to 
differences in the conditions of the tumour at diagnosis, as represented by stage and 
morphology (results for grade follow in the next chapter). The results reported in tables 4-3, 
4-4, 4-5,4-6, 4-7 and 4-8 are relevant to this question.
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4-3. Adjusted effects - basic results
Consider first Table 4-3 for all deaths, which reports estimated hazard ratios and 
corresponding 95% confidence intervals for the four non-reference categories of the variable 
deprivation, calculated by adjusting for stage and age. These estimates have been calculated 
without distinguishing between those death events which are clearly related to breast cancer 
and those which are not. The results in this part show that adjusting for stage does change the 
point value and the confidence interval of the hazard ratio estimates but the most deprived 
category still has a significantly higher HR than the least. An interpretation of this finding is 
that the apparent hazard disadvantage of women in the most deprived category can be partly 
but not completely explained in terms of a poorer stage of the tumour at diagnosis.
Table 4-3 for breast cancer deaths only reports estimated hazard ratios and corresponding 95% 
confidence intervals associated with the deprivation categories, again adjusting for stage and 
age, focusing on only those death events which are clearly related to breast cancer, that is, 
treating all other deaths as censoring events. The hazard ratio estimates in this section of the 
table are not substantially different from those of all causes of death, in terms of point 
estimates, although their corresponding confidence intervals are much larger. The latter fact 
can be interpreted to be an effect of the higher degree of censoring and fewer events due to 
discarding non-breast-cancer deaths, with a consequent loss of statistical power. The hazard 
ratio for the most deprived category is augmented rather than attenuated by adjustment for 
stage.
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Table 4-3: Deprivation effect on survival adjusted for age and stage
Deprivation
All deaths Breast cancer deaths
H.R. (95% Cl) H.R. (95% Cl)
Most affluent 1.00 — 1.00 —
2 1.05 0.98-1.14 1.04 0.89-1.22
3 1.01 0.94-1.09 1.01 0.86-1.19
4 1.02 0.94-1.11 0.98 0.82-1.17
Most deprived 1.16 1.03-1.31 1.23 0.96-1.55
Table 4-4 shows hazard ratio estimates for the deprivation categories adjusting for age and 
morphology, taking all deaths as endpoints in the first part of table and then breast cancer 
deaths only in the second. The results in this table show that adjusting for morphology for 
either endpoint does not change point and interval hazard ratio estimates substantially. In 
particular, the hazard ratio associated with the most deprived category does not appear to be 
substantially modified by the adjusting, neither in point estimate nor in interval. This suggests 
that the apparent hazard disadvantage of women in the most deprived category cannot be 
explained in terms of a more unfavourable morphology of the tumour at diagnosis. Confidence 
intervals on the breast cancer deaths estimates are wider than the corresponding ones in the all 
deaths part of the table as before.
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Table 4-4: Deprivation effect on survival adjusted for age and morphology
Deprivation
categories
All deaths Breast cancer deaths
HR (95% Cl) H.R. (95% Cl)
Most affluent 1.00 — 1.00 —
2 1.02 0.95-1.10 1.02 0.87-1.19
3 1.02 0.95-1.09 1.03 0.88-1.20
4 1.02 0.95-1.11 1.00 0.85-1.21
Most deprived 1.24 1.11-1.38 1.23 0.96-1.55
Table 4-5 shows the estimated hazard ratio for low social class, adjusting for age and stage, 
using all deaths as failure events and breast cancer deaths separately, as before. Interestingly, a 
comparison of Tables 4-2 and table 4-5, all deaths section, shows that adjusting for stage 
causes a substantial reduction in the estimated hazard ratio, making it practically 
indistinguishable from its null value 1. This finding would seem to suggest that when all 
deaths are considered the hazard disadvantage of lower social class women is to a great extent 
explained as being a consequence of a more advanced stage of the tumour at diagnosis. The 
second part of table 4-5 reports the estimated hazard ratio associated with a lower social class, 
after adjusting for age and stage, taking only those deaths which were clearly related to breast 
cancer as failure events. The results in this part of table show that, unlike in the all deaths 
analysis, adjusting for stage causes a considerably smaller reduction in the estimated hazard 
ratio associated with social class. The latter remains significant after adjustment. A possible
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combined interpretation of the results of Table 4-5is the following: a higher tumour stage at 
diagnosis might well explain the disadvantage of lower social class women in terms of the 
overall death rate, but to a lesser extent their disadvantage in terms of that component of the 
hazard of death which is strictly related to breast cancer. This finding needs further research 
to confirm and clarify it.
Table 4-5: Effect of social class on survival after adjusting for age and stage
Social class
All deaths Breast cancer deaths
H.R. (95% Cl) H.R. (95% Cl)
High 1.00 1.00 ———
Low 1.07 0.97-1.18 1.22 1.03-1.44
T a b le  4-6: Effect of social class on survival after adjusting for age and 
morphology.
Social class
All deaths Breast cancer deaths
H.R. (95% Cl) H.R. (95% Cl)
High 1.00 — 1.00 —
Low 1.19 1.09-1.31 1.31 1.12-1.54
Table 4-6 shows the hazard ratio estimates for the social class categories adjusting for age and 
morphology. The result in this table suggest that the apparent hazard disadvantage of women 
in low social class cannot be substantially explained in term of more unfavourable
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morphology of tumour at the time of presentation. This is particularly so when analysis is 
restricted to breast cancer deaths.
It should be noted that adjusting for both stage and morphology simultaneously does not 
change the odds ratios markedly from those adjusted for stage alone. This is the case for both 
measures of socioeconomic status and both death endpoints.
4-4. Adjusted effects- summary and implications
To draw together the adjusted and unadjusted effects, see Table 4.7. In this table the 
unadjusted and adjusted hazard ratios for low social class and the most deprived category are 
shown, by death endpoint and adjusting variable. It can be seen clearly that morphological 
type does not account for a substantial proportion of the effect of either socioeconomic 
measure on either death endpoint. Stage, interestingly, accounts for some of the effect of 
social class on hazard of breast cancer death and all deaths, but only accounts for a proportion 
of the deprivation effect on all deaths.
The corresponding Freedman statistics for the percentage explained are shown in Table 4-8. 
The table shows that stage accounts for around 31-63% of the effect of socio-economic status 
on survival to death from all causes, and 0-28% of the effect on survival to death from breast 
cancer specifically. Morphology does not substantially explain any socioeconomic effects on 
survival. It is interesting that the percentage effect explained by stage is greater for social class 
than for area-based deprivation category. This suggests that there are aspects of 
socioeconomic status which bear on the survival of breast cancer patients which are
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encompassed by the deprivation category but not by social class (which is based on occupation 
alone).
Another interesting point is the fact that stage accounts for a greater proportion of the effect of 
socioeconomic status on all-cause deaths than on breast cancer deaths specifically. It is not 
clear why this should be so. It is understandable that breast cancer patients of lower 
socioeconomic status have higher death rates from whatever cause, due to the general 
association of poverty with ill-health, but it is less clear why stage of breast cancer should 
account for some of the deaths from other causes than breast cancer. Possible explanations are:
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(1) misclassification of cause of death, in that some deaths from other causes may be due 
at least in part to the breast cancer;
(2) there may be some deaths occurring as a result of more aggressive treatments 
administered to advanced stage patients, which are not classified as breast cancer 
deaths; or
(3) Confounding of stage of disease with other aspects of low socioeconomic status which 
contribute to an increased overall mortality rate.
Disentangling these is a target for future research.
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Table 4-7: Adjusted and unadjusted effects of socioeconomic status, stratified by death 
endpoint (breast cancer or all causes), measure of socioeconomic status (social class or 
deprivation category) and adjusting variable (stage or morphology).
Socioeconomic 
status variable
Adjusting
variable
Adjusted? All deaths Breast cancer deaths
H.R. (95% Cl) H.R. (95% Cl)
Social class Stage No 1.20 (1.09-1.32) 1.32 (1.12-1.55)
Yes 1.07 (0.97-1.18) 1.22 (1.03-1.44)
Social class Morphology No 1.20 (1.09-1.32) 1.32 (1.12-1.55)
Yes 1.19 (1.09-1.31) 1.31 (1.12-1.54)
Deprivation Stage No 1.24 (1.11-1.39) 1.21 (0.95-1.54)
Yes 1.16 (1.03-1.31) 1.23 (0.96-1.55)
Deprivation Morphology No 1.24 (1.11-1.39) 1.21 (0.95-1.54
Yes 1.24 (1.11-1.38) 1.23 (0.95-1.55)
Table 4-8: Freedman estimates of the percentages of effects of socioeconomic status 
explained by stage and morphological type, stratified by death endpoint (breast cancer or all 
causes).
Socioeconomic Adjusting % explained
status measure variable All cause 
deaths
: Breast cancer 
deaths
Social class Stage 63% 28%
Social class Morphology 5% 3%
Deprivation Stage 31% 0%
Deprivation Morphology 0% 0%
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CHAPTER 5
5. Additional analyses of histological grade data
5-1. Additional data
A total of 1573 breast cancer cases diagnosed between 1982 and 1993 had recorded grade. 
Because of the small numbers with recorded grade, we dispensed with the limits on year of 
diagnosis and used all data available until 1998. This gave 6199 cases with grade recorded as 
shown in table 5-1.
Table 5-1: Frequency distribution of histological grade, tumour diagnosed in 1982-1998.
Grade Frequency Percent
1 1358 22.0
2 2778 44.8
3 2063 33.2
Total 6199 100.00
The distribution of grade in this table using the larger tumour series from the longer time 
interval (1982-1998) is similar to the proportions observed in the shorter interval of 1982-1993
64
in table 2-3. One difference is the smaller number of grade 3 cases in the larger series, 33.2% 
compared to the 40% shown in table 2-3.
The highest proportion of patients presented with grade 2 disease, with 44.8%, while the 
patients with grade 1 cancers formed the lowest proportion with 22.0%.
Table 5-2: Association of grade and social class among women with breast cancer 
diagnosed between 1982-1998, EACR
Social class
Grade High Low Total
No. (%) No. (%) No. (%)
1 309 (19.2) 221 (20.8) 530 (19.9)
2 689 (42.9) 464 (43.8) 1153 (43.2)
3 608 (37.9) 375 (35.4) 983 (36.9)
Total 1606 (100.00) 1060 (100.00) 2666 (100.00)
%2 =2.01, 2 d.f., Not Significant
The association between grade and social class (dichotomised as in previous chapters) is 
shown in Table 5-2. This association was not substantially different from that observed with 
the smaller sample size. Note that a total of 2666 cases had both social class and grade 
records. Thus, of those with grade recorded, social class was only available for a minority of 
cases. This minority may not be representative, so results should be interpreted with caution. 
A chi-squared comparison showed no significant association between social class and grade. 
In both the higher and lower social classes, grade 2 cancers were the most frequently 
observed, with 42.9% and 43.8% respectively.
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Table 5-3: Association of grade with deprivation among women with breast cancer
diagnosed between 1982 and 1998, EACR.
Grade
Deprivation category
TotalMost affluent 2 3 4 Most deprived
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
1 362(22.82) 380(21.90) 356(23.62) 187(18.23) 73(21.16) 1358(21.91)
2 669(42.18) 808(46.57) 672(44.60) 479(46.67) 150(43.48) 2778(44.81)
3 555(35.00) 547(31.53) 479(31.78) 360(35.10) 122(35.36) 2063(33.28)
Total 1586(100) 1735(100) 1507(100) 1026(100) 345 (100) 6199 (100)
X2 =19.45, 8 d.f., p=0.02
Table 5-3 shows the association between grade and deprivation. The association was 
statistically significant, although the absolute magnitude of the differences in grade 
distribution among deprivation categories was small. The more deprived categories had 
slightly poorer histological grade than the more affluent.
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5.2 Survival by grade, social class and deprivation category- death from any
cause
Table 5.4 shows the unadjusted effect of histological grade on survival to death from any 
cause. The effect of grade on survival is very significant, unadjusted for other variables. As 
one would expect, the results in this table show an increasing risk of death with higher grade. 
Note that in this larger tumour series, the hazard ratio for grade 3 tumours is larger, at 3.18 
compared to 2.62 in table 4-2.
Table 5-4: Unadjusted Hazard ratio for histological grade, considering all causes of deaths
Grade Haz. Ratio 95% Conf. Interval
1 1.00 -
2 1.99 1.63-2.42
3 3.18 2.62-3.85
Table 5-5 shows the unadjusted effect of deprivation category on survival to death from any 
cause. The effect of deprivation, in terms of the estimated hazard ratios, was not substantially 
changed by using the larger number of cases. The unadjusted effect of deprivation on survival 
was significant using all causes of death as the failure event. As before, the major 
manifestation of the effect is in an increased hazard of death in the most deprived category.
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Table 5-5: The effect of deprivation (unadjusted) on breast cancer survival, considering all
causes of deaths. 1982-1998.
Deprivation Haz. Ratio 95% Con. Interval
Most affluent 1.00 -
2 1.06 1.00-1.13
3 1.08 1.01-1.15
4 1.11 1.03-1.19
Most deprived 1.26 1.15-1.40
Table 5-6: The effect of Social class (unadjusted) on breast cancer survival, considering all 
causes of deaths. 1982-1998.
Social class Haz. Ratio 95% Con. Interval
High 1.00 -
Low 1.25 1.16-1.36
Table 5-6 shows the unadjusted effect of social class on survival, taking all cases between 
1982 and 1998 and using all causes of death as endpoint. The hazard for the lower social 
classes is significantly higher than that for the higher classes, as was observed with the smaller 
tumour series in table 4-2.
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Table 5-7: The effect of Social class on breast cancer survival, adjusted for grade,
considering all causes of deaths. 1982-1998.
Factor / category Haz. Ratio 95% Conf. Interval
Social class High 1.00 -
Low 1.33 1.15-1.56
Grade
1 1.00 -
2 1.94 1.46-2.57
3 3.37 2.57-4.43
Table 5-7 shows the estimated hazard ratio for lower social classes adjusting for grade, using 
all deaths as failure events. Interestingly, adjusting for grade has increased the estimated 
hazard ratio from 1.25 to 1.33. This finding might suggest that when all deaths are considered, 
the survival disadvantage of lower social class women is increased after adjusting for grade, 
possibly as a result of negative confounding. On the other hand, the difference between the 
unadjusted and adjusted hazard ratios is small, so this may be a chance finding.
Table 5-8 shows the hazard ratio estimates for the deprivation categories adjusting for grade. 
The significance of the effect of deprivation was reduced when adjusted for grade. The hazard 
ratio for the most deprived category, however, increased when adjusted for grade. The results 
suggest that the apparent survival disadvantage of women in the most deprived group cannot 
be explained in terms of tumour grade at diagnosis.
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Table 5-8: The effect of deprivation (based on residential area) on breast cancer survival,
adjusted for grade, considering all causes of deaths. 1982-1998
Factor / category Haz. Ratio 95% Conf. Interval
G
rade
1 1.00 -
2 1.98 1.62-2.41
3 3.17 2.61-3.84
Most affluent 1.00 -
2 1.08 0.92-1.25
>1
5s'u>
3 1.01 0.86-1.18
O
P 4 1.14 0.96-1.34
Most deprived 1.49 0.90-1.46
5.3. Grade, social class, deprivation category and survival- breast cancer 
deaths only
Table 5-9 shows the unadjusted effect of grade on survival to death from breast cancer.
A significant effect of grade was observed, with a considerably steeper gradient of risk than 
was observed using all causes of death as the endpoint. In particular, the estimated hazard ratio 
of 7.39 associated with grade 3 disease is very striking. Clearly, the use of all causes of death 
dilutes the effect of histological grade by the inclusion of deaths which are not affected by the 
basic characteristics of the tumour.
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Table 5-9: Unadjusted hazard ratios for histological grade, considering breast cancer
deaths only, 1982-1998.
Grade Haz. Ratio 95% Conf. Interval
1 1.00 -
2 3.43 2.32-5.06
3 7.39 5.06-10.80
Table 5-10: The effect of social class (unadjusted) on breast cancer survival, considering 
breast cancer deaths only. 1982-1998.
Social class Haz. Ratio 95% Conf. Interval
High 1.00 -
Low 1.40 1.23-1.59
Table 5-10 shows the unadjusted effect of social class on survival to death from breast cancer. 
The estimated hazard ratio for the lower social classes was 1.40, highly significant, and 
showing an effect of greater size than observed using all causes of death as the endpoint. It is 
also larger than the hazard ratio observed in the smaller tumour series from 1982-93.
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Table 5-11: The effect of Deprivation (unadjusted) on breast cancer survival, considering
breast cancer deaths only. 1982-1998.
Deprivation Haz. Ratio 95% Conf. Interval
Most affluent 1.00 -
2 1.04 0.92-1.18
3 1.03 0.91-1.17
4 1.04 0.91-1.20
Most deprived 1.21 1.00-1.48
Table 5-11 shows the unadjusted effect of deprivation category on survival to death from 
breast cancer. The effect of deprivation was similar to that observed in the initial analysis in 
table 4-1. The most deprived women had a borderline significant hazard ratio of 1.21.
Table 5-12 reports the estimated hazard ratio and 95% confidence interval associated for 
deprivation categories after adjusting for grade, for breast cancer deaths only. Although the 
hazard ratio estimate for the most deprived category was no longer significant when adjusted 
for grade, it is of the same magnitude as the unadjusted estimate. Also, the hazard ratio for the 
second most deprived category has increased with adjustment for grade. We cannot therefore 
conclude that the effect of deprivation on survival can be accounted for by a difference among 
deprivation categories with respect to histological grade.
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Table 5-12: The effect of deprivation (based on residential area) on breast cancer survival,
adjusted for grade, considering breast cancer deaths only. 1982-1998
Factor/category Haz. Ratio 95% Conf. Interval
G
rade
1 1.00 -
2 3.40 2.30-5.02
3 7.33 5.02-10.71
Most affluent 1.00 -
rt>
2 1.06 0.84-1.34
5*' 3 1.09 0.86-1.38
O
3 4 1.26 0.98-1.61
Most deprived 1.23 0.87-1.75
Table 5-13: The effect of Social class on breast cancer survival, adjusted for grade, 
considering breast cancer deaths only. 1982-1998.
Factor/category Haz. Ratio 95% Conf. Interval
Social class
High 1.00 -
Low 1.48 1.19-1.84
Grade
1 1.00 -
2 4.13 2.27-7.49
3 9.61 5.38-17.18
73
Table 5-13 reports the estimated hazard ratios associated with lower social class after 
adjusting for grade, taking only breast cancer deaths as failure events. The hazard ratio for 
lower social classes increased from 1.40 (Cl, 1.23-1.59) to 1.48 (Cl, 1.19-1.84) when adjusted 
for grade. This finding might again suggest that grade is a negative confounder of social class, 
or it may be a chance finding. At any rate, the poorer survival of women in the lower social 
classes cannot be attributed to differences in histological grade on the basis of these results.
5.4. Discussion
Table 5.14 summarises the findings of sections 5.2 and 5.3. It can be seen that the role of 
tumour grade in explaining the effect of deprivation and social class on breast cancer survival 
was not considerably substantial for either failure endpoint in our study. After using all the 
available data to increase the sample size, we found that grade does not account for the effect 
of social class or for that of deprivation category. Indeed, the hazard ratios associated with 
lower social class or deprivation actually increased somewhat after adjustment for grade. This 
result might suggest histological grade as a negative confounder of social class and 
deprivation. As regards social class, Table 5-2 shows some weak evidence for this, in that 
there were slightly fewer grade 3 tumours in the lower social classes, but this difference was 
not substantial or statistically significant. There may therefore be weak negative confounding 
of grade with social class, but this cannot be reliably distinguished from random variation. 
Table 5-3 suggests if anything positive confounding of deprivation category with grade, in that 
there are slightly fewer grade 1 tumour in the two most deprived categories.
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Table 5-14: Grade-adjusted and unadjusted effects of socioeconomic status, stratified by death 
endpoint (breast cancer or all causes) measure of socioeconomic status (social class and 
deprivation categories).
Socioeconomic 
status category
Adjusted? All deaths Breast cancer deaths
H.R 95% Cl H.R 95% Cl
Lower social class Yes 1.33 1.15-1.56 1.48 1.19-1.84
No 1.25 1.16-1.36 1.40 1.23-1.59
Most deprived Yes 1.49 0.90-1.46 1.23 0.87-1.75
No 1.26 1.15-1.40 1.21 1.00-1.48
Our results suggest, therefore that differences in histological grade of the tumours does not 
account for socioeconomic differences in survival. However, our interpretation must be 
qualified by the fact that these results came from analyses of that minority of cases with data 
on grade, including tumours diagnosed more recently. That minority may not be 
representative, and follow-up for the most recent cases may not be complete. Future analyses 
of data when reliable long-term follow-up is available on cases diagnosed since the 1990’s, 
when grade is routinely recorded on the majority of tumours, will yield more conclusive 
results.
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CHAPTER 6
Discussion, conclusions and implications for future work
The major finding of this work is that we could not wholly or even largely account for 
socioeconomic effects on breast cancer survival by pathological factors including disease 
stage, morphology or grade. We used two socioeconomic measures in this study, one an area- 
of-residence-based deprivation index, the other the traditional occupation-based social class. 
The area-based deprivation score used was the Carstairs' Index. This is a proxy measure of 
deprivation, based on small area measures of overcrowding, unemployment, social class 
(occupation) and car ownership. It has been shown that area-based deprivation has a stronger 
association with cancer mortality than the occupation-based social class (Carstairs et al 1991). 
In addition, the Carstairs index was shown to adjust more fully for socioeconomic imbalances 
in the Edinburgh Breast Screening Trial (Alexander et al, 1998; Alexander et al, 1999).
Several studies have examined the effect of area-based deprivation on disparity of survival in 
breast cancer patients (Schrijvers et al 1995 a; Camon et al 1994; Garvican et al 1998).
Despite this, the effect of socioeconomic status on breast cancer survival remains a complex 
issue. Patients of low socioeconomic status tend to have poorer survival from many other 
diseases, so it is very likely that there is a complex mix of host, environmental and healthcare 
delivery factors involved in the poorer prognosis. Researchers noted as early as 1977 the 
importance of host factors in the poorer survival of patients of low socioeconomic status (Berg 
etal, 1977).
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The results of this study add further to the evidence of an increased risk of death in breast 
cancer patients of low socioeconomic status, whether measured occupationally as social class 
or by an area-based method. They also suggest that this increased risk is not entirely 
attributable to morphological type or stage of disease. Although stage tends to account for 
more of the effect, particularly of the social class measure, there is still a substantial 
proportion of the effect unaccounted for by stage or by stage and morphology both together. 
This is consistent with the findings of Thomson et al (2001), who observed that oestrogen 
receptor status and treatment factors accounted for only 20% of the difference in survival 
between patients of high and low socioeconomic status (as measured by area of residence). 
Similarly, Newman et al (2002) found that the survival differences by ethnic group in the US 
could not be accounted for by stage of disease. Similarly, Ansell et al (1993) found that 
despite significantly poorer stage in black American women, this still did not explain the 
poorer survival of the latter group. Interestingly, Bassett and Krieger (1986), also studying US 
black and white women, found that socioeconomic status was a more important prognostic 
factor in breast cancer than ethnic group and indeed that socioeconomic status explained most 
of the survival difference between black and white women. This was also suggested by the 
study of Gordon et al (1992) and the earlier work of Berg et al (1977). In Finland, Karjalainen 
et al (1990) found social class to be a significant prognostic factor in breast cancer survival, 
and its effect was only partly explained by differences in stage of tumour at the time of 
diagnosis.
One point which should be made is that stage of disease is a classification of a continuous 
tumour burden into a number of discrete classes, some of which are very broad. There is, for 
example, considerable scope for residual effects and residual confounding with socioeconomic 
status within stage II disease, which can encompass tumours of sizes 2 to 5 cm. Thus a more
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detailed measure of the state of advancement of the tumour, involving size and lymph node 
status, including number of involved lymph nodes, might account for considerably more of the 
socioeconomic effects on survival.
Nevertheless, we did find significantly poorer stage at presentation in patients of lower 
socioeconomic status, and this accounted for some of the differences in survival. This is in 
disagreement with the findings of Camon et al (1994), who reported no significant differences 
between socioeconomic groups with respect to tumour size or node status. Ansell et al (1993) 
also reported no significant differences between blacks and whites with regard to stage at the 
time of diagnosis. Our results are, however, partly consistent with those of Macleod et al 
(2000a) who reported a higher rate of clinically determined locally advanced disease in 
patients resident in deprived areas. Mandelblatt et al (1991) also found that breast cancer 
patients of low socioeconomic status were at high risk of late stage disease. Brewster et al 
(2001) reported no significant differences in stage among socioeconomic groups, but a 
reanalysis of their tabular data on tumour size in breast cancer patients shows a significant 
trend of increasing size with deprivation (% =5.17, 1 degree of freedom, P=0.02). Thus, there 
is some support in the literature for our observed association of stage and socioeconomic 
status.
The poorer stage in women of lower socioeconomic status may be addressed by screening, but 
it is unlikely in this data set to be explained by differential uptake of screening. This is because 
most of our tumours were diagnosed before screening was widespread in East Anglia.
In this study, the distribution of morphological type was associated with socioeconomic status, 
but it is difficult to interpret this since 40% of the cases were classified simply as
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adenocarcinoma or 'other'. An association of morphological type with socioeconomic status is 
not entirely unexpected, since Thomson et al (2001) found a significant association between 
deprivation category and oestrogen receptor status. More thorough morphological typing 
might account for more of the survival effect of socioeconomic status.
Only limited information was available from East Anglian Cancer Registry records for 
histological grade, although in recent years, histological grade has been registered in the 
majority of cases. Therefore the findings of this study with respect to grade must be 
interpreted with caution because of the large percentage with grade missing, and the short 
follow-up on average of those with grade known. At any rate, tumour grade in this study does 
not account for the effect of either social class or deprivation on survival. There remain some 
uncertainties, as only 2666 subjects in total have both grade and social class recorded. When 
further follow-up of recent cases becomes available, it will be possible to assess with more 
confidence the extent to which histological grade may account for socioeconomic differences 
in survival. Since it is known that some risk factors, notably family history, vary in their effect 
on risk by histological grade (Duffy et al, 1999) and it is likely that in some cases, histological 
grade may actually deteriorate as the tumour grows (Tabar et al, 1996), there is at least a 
possibility that grade is implicated in the prognostic effect of socioeconomic status.
The association of social class with survival was essentially manifested as a threshold effect, a 
difference between the non-manual and manual occupations. The association of deprivation 
category was essentially an increased hazard of death for the most deprived category, and very 
little difference in risk among the other four categories.
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The association of survival with socioeconomic status (measured by either means) remained 
significant or close to significant after adjustment for stage or morphological type or both. It is 
notable that the adjustment accounted for a greater proportion of the survival effect for death 
from any cause than for breast cancer as the underlying cause of death. This may be due to 
misclassification of cause of death, a direct effect of tumour attributes on deaths from other 
causes or an increased risk of death from other causes in association with more aggressive 
treatment of more advanced tumours. Also, it is of interest that whereas deprivation category 
was not significant as a predictor of breast cancer death (although it was so for all-cause 
deaths), its effect was more robust to adjustment. Stage accounted for at least part of the effect 
of social class but for none of the effect of deprivation category, suggesting that the non- 
occupational aspects of poverty captured by the deprivation score are associated with survival 
independently of stage of disease. This may be related to either host factors that affect survival 
generally or poorer access to prompt and appropriate therapy.
In the survival analysis for the deprivation category, the most striking result was that rather 
than a smooth trend with deprivation, the lowest category had poorer survival, and the other 
four categories had similar survival to each other. It is not clear why this should be. Further 
studies with individual rather than area-based deprivation measures might clarify this.
Among the most deprived and lowest social class patients, in addition to stage at diagnosis, 
impairment of host resistance could be related to lower social support, nutritional 
disadvantage, and psychological factors. There are also some aspects of the health care system 
which could be related to the lower survival of the lower socioeconomic groups. These 
include; type of treatment, its quality and appropriateness, adverse hospital referral patterns of 
treatment and worse compliance with treatment in this group of patients. Poorer compliance
with treatment is unlikely to be an explanation, however, since the vast majority of breast 
cancer patients complete their recommended course or courses of therapy. For most of these 
factors, appropriate information is not available from routine registry data. Therefore 
prospective analytic studies will need to be designed to investigate their impact on survival 
and the extent to which they account for socioeconomic effects on survival.
The conclusions of the above are:
1. Survival rates in East Anglia confirm the poorer survival of breast cancer patients of 
lower socioeconomic status.
2. Although, this is not fully accounted for by differences in stage at presentation and 
morphological type, stage does account for at least a proportion of the poorer survival 
of women of low socioeconomic status , and the latter may be amenable to improve 
access to and uptake of screening.
3. Assessment of the extent to which histological grade and other biological features 
account for the poorer survival of patients with lower socioeconomic status is a target 
for future research.
4. More detailed classification of stage of disease, including separate classification of 
tumour size and node status, may account for a greater proportion of the 
socioeconomic effects.
5. Research is needed on access to, and timing of and compliance with appropriate 
treatment in relation to socioeconomic status. This will require ad hoc prospective 
studies, as will 6 and 7 below.
6. Taken together, the findings of this study suggest that the socioeconomic status can
account for at least part of observed differences in breast cancer survival. It would be
useful to confirm these findings in additional studies that include other individual
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socioeconomic indices in addition to area-based and occupational measures. These 
might include educational status.
7. It has been observed that patients of lower socioeconomic status have poorer survival 
in many chronic diseases in addition to breast cancer. There is therefore score for 
research on measures of general health status and their joint association with both 
socioeconomic status and survival from breast cancer and other diseases.
82
REFERENCES
Alexander FE, Anderson TJ, Brown HK, Forrest APM, Hepburn W, Kirkpatrick AE, Muir 
BB, Prescott RJ, Smith A (1999) 14 years of follow-up from the Edinburgh randomized trial 
of breast-cancer screening, Lancet; 353:1903-08.
Alexander FE, Brown H, Prescott RJ. (1998) Improved classification of socio-economic status 
explains differences in all-cause mortality in a randomized trial of breast cancer screening. J  
Epidemiol Biostat; 3: 219-24.
Ansell D, Whitman S, Lipton R, Cooper R (1993) Race, Income, and survival from breast 
cancer at two public hospitals, Cancer 72: 2974-2978.
Auvinen A, Karjalainen S, Pukkala E (1999) Social class and cancer patient survival in 
Finland, American Journal o f Epidemiology 142: 1889-1102.
Baquet C R, Commiskey P (2000) Socioeconomic factors and breast carcinoma in 
multicultural women, American Cancer Society 88: 1256-1264.
Bassett M T & Kriger N (1986) Social class and black white differences in breast cancer 
survival, American Journal o f Public Health. 76: 1400-1403.
83
Berg J, Ross R, Latourette HB (1977) Economic status and survival of cancer patients. Cancer, 
39: 467-77.
Berrino F, Sant M, Ver dechia A, Capocaccia R, Hakulinent et al (1995) Survival of Cancer 
patient in Europe, The Euro care study. Scientific publications No. 132: LYON: IARC.
Bibb S C (2000) Access and late-stage diagnosis of breast cancer in the military health system, 
Mil Med. 165: 585-90.
Boffeta P, Merltti F, Winkelmann R, et al (1993) Survival of breast cancer patients from 
predmont, Italy. Cancer causes control, 4: 209-215.
Brewster D H, Thomson C S, Hole D J, Black R J, Stoner P L, Gillis C R (2001) Relation 
between socioeconomic status and tumour stage in patients with breast, colorectal, ovarian, 
and lung cancer: results from four national, population based studies. British Medical Journal 
322: 830-831.
Cancer statistics registrations England and Wales. OPCS Series MB1 No. 22 1989. HMSO,
1995.
Camon A G, Semwogerere A, Lamont D W, Hole D J, Mallon E A, et al (1994) Relation 
between socioeconomic deprivation and pathological prognostic factors in women with breast 
cancer, British Medical Journal 309: 1054-1057.
84
Carstairs V, Morris R (1989) Deprivation: explaining differences in mortality between 
Scotland and England and Wales, British Medical Journal 299: 886-89.
Carstairs V, Morris G. Deprivation and Health in Scotland. Aberdeen: Aberdeen University 
Press 1991.
Cohart E M (1955) Socioeconomic distribution of cancer of the female sex organs in new 
Haven, Cancer 8: 34-41.
Coleman M P, Babb P, Damiecki P, Grosclaude P, Honjo S, Jones J, et al (1999) Cancer 
survival trends in England and Wales. 1971-1995: Deprivation and NHS region. London: The 
Stationery Office.
Cox D R (1972) Regression models and life tables. J  Roy Statist Soc B 34: 187-220.
Dayal HH, Power RN, Chiu C (1982) Race and socioeconomic status in survival from breast 
cancer, JChron Dis 35: 675-83.
Duffy S W, Tabar L, Smith RA, Krosemo UB, Prevost TC, Chen HH (1999) Risk of breast 
cancer and risk with breast cancer: the relationship of histologic type with epidemiology, 
disease progression and survival. Semin Breast Dis 2: 292-300.
85
Eley J W, Hill H A, Chen V W, Austin D F, Wesley M N, et al (1994) Racial differences in 
survival from breast cancer. Results of the National Cancer Institute black-white cancer 
survival study, JAMA 272: 947-954.
Forbes J F (1997) The control of breast cancer: The role of tamoxifen, Seminars in Oncol 24: 
Suppl 1:5-19.
Freedman L S, Graubard B I, Schatzkin A (1992) Statistical validation of intermediate 
endpoints for chronic diseases. Stat Med 11: 167-178.
Freeman P H & Wasfie T J (1989) Cancer of the breast in poor black women, Cancer 63: 
2562-2569.
Garvican L & Littlejohns P (1998) Comparison of prognostic and socio-economic factors in 
screen-detected and symptomatic cases of breast cancer, Public Health 112: 15-20.
Gordon N H, Crowe J P, Brumberg D J, Berger N A (1992) Socioeconomic factors and race in 
breast cancer recurrence and survival, American Journal o f Epidemiology 135: 609-618.
Harris V, Sandridge A L, Black R J, Brewster D H, Gould A. Cancer Registration Statistics 
Scotland 1986-1995. Edinburgh: Scottish Cancer Intelligence Unit, ISD Scotland Publication, 
1998.
86
Hsu J L, Glaser S L, West D W (1997) Racial-ethnic differences in breast cancer survival 
among San Francisco Bay Area Women, J  Natl Cancer Inst 89: 1311-1312.
Hunter CP (2000) Epidemiology, stage at diagnosis, and tumour biology of breast carcinoma 
in multiracial and multiethnic populations, Cancer 88: (Suppl), 1193-2001.
Jarman B (1983) Identification of under privileged areas, Br. Med J. Clin. Res. Ed 286: 1705- 
1709.
i
Karjalanen S, et al (1990), Social class as a prognostic factor in breast cancer survival. Cancer 
66: 819-826.
Kogevinas M, et al (1990) OPCS longitudinal study, socio-demographic differences in cancer 
survival (series LS NO 5). London, Her Maesty’s Stationery office. Pp. 1971-1983.
Kogevinas M, Marmot M G, Fox A J, Goldblatt P O (1991) Socioeconomic differences in 
cancer survival, Journal of Epidemiology and Community Health 45: 216-219.
Lemarchand L. et al (1984), Relationship of ethnicity and other prognostic factors to breast 
cancer survival in Hawaii. J. Natl, Cancer inst, 73: 1259-1263.
Macleod U, Ross S, Twelves C, George W D, Gillis C, Watt G C (2000a) Primary and 
secondary management of women with early breast cancer from affluent and deprived areas: 
retrospective review of hospital and general practice records. Br M edJ320: 1442-1445.
87
Macleod U, Ross S, Gillis C, McConnachie A, Twelves C, Watt GC (2000b) Socio-economic 
deprivation and stage of disease at presentation in women with breast cancer. Ann Oncol 11: 
105-107.
Mandelblatt J, Andrews H, Kemer J, Zauber A, Burnett W (1991) Determinants of Late stage 
diagnosis of breast and cervical cancer: The impact of age, race, social class and hospital type, 
American Journal o f Public Health 81: 646-649.
Nadakumar A; et al (1995) Survival in breast cancer, a population based study in Bangalore, 
India, International Journal o f Cancer 60: 593-596.
National Statistics, Cancer registrations in England, 2000.
Newman L A, Bunner S, Carolin K, Bouwman D, Kosir M A, White M, Schwartz A (2002) 
Ethnicity related differences in the survival of young breast carcinoma patients. Cancer 95: 
21-27.
OPCS (1992) Mortality statistics: Cause. England and Wales.
Pollock A M, Vickers N (1997) Breast, lung and colorectal cancer incidence and survival in 
South Thames Region, 1987-1992: The effect of social deprivation. Journal o f  Public Health 
Medicine 19: 288-294.
Richardson J L, Langholz B, Bernstein L, Burciaga C, Danley K, Ross K K (1992) Stage and 
delay in breast cancer diagnosis by race, socioeconomic status, age and year, British Journal 
o f Cancer 65: 922-926.
Ries L A G ,  Kosary C K L, Hankey B F, et al( 1999) SEER Cancer Statistics Review 1973-
1996. National Cancer Institute, Bethesda, MD USA.
Schrijvers, C T M & Mackenbach J P (1994) Cancer patient survival by socioeconomic status 
in the Netherlands: a review for six common cancer sites, Journal o f Epidemiology and 
Community Health 48: 441-446.
Schrijvers C T M (1995b), Socioeconomic variation in breast cancer survival in the Southern 
Netherlands, 1980-1989, Cancer 75: 2946-2953.
Schrijvers. C T M, Coebergh J W W , Van der Heijden L H, Mackenbach J P (1995 c) 
Socioeconomic status and breast cancer survival in the southern Netherlands, 1980-1989, 
European Journal o f Cancer 31: 1660-1664.
Schrijvers. C T M, Mackenbach J P, Lutz J M, Quinn M J, Coleman M P (1995 a) Deprivation 
and survival from breast cancer, British Journal o f Cancer 72: 738-743.
Scottish Office Department of Health. Working together for a healthier Scotland: a 
consultation document. Edinburgh: Stationery Office, 1998.
89
Sondik E J (1994) Breast cancer trends: Incidence, mortality and survival, Cancer 74: 995- 
999.
Swerdlow A, dos Santos Silva I, Doll R (2001) Cancer Incidence and Mortality in England 
and Wales. Trends and Risk Factors. Oxford: Oxford University Press.
Tabar L, Fagerberg G, Chen HH, Duffy SW, Gad A (1996) Tumour development, histology 
and grade of breast cancers: prognosis and progression, In tJ  Cancer 66: 413-419.
Taylor R (1997) Breast cancer five-year survival, by New South Wales regions, 1980-1991, 
Australian and New Zealand Journal o f Public Health 21: 206-210.
Thomson C S, Hole D J, Twelves C J, Brewster D H, Black R J (2001) Prognostic factors in 
women with breast cancer: distribution by socioeconomic status and effect on differences in 
survival, Journal o f Epidemiology & Community Health 55:308-315.
Townsend P, Phillimore P, Beattie A (1986) Inequalities in health in the Northern Region. 
Newcastle Upon Tyne: Northern Regional Health Authority and university of Bristol.
Vagero D & Persson G (1987) Cancer survival and social class in Sweden, Journal o f  
Epidemiology and Community Health 41: 204-209.
90
Waxier M (1991) Effect of social relationships on survival for women with breast cancer, a 
prospective study, Social Science and Medicine 33: 177-183.
Young Jr J L, Ries L G, Pollack E S (1981) Cancer patient survival among ethnic groups in 
the United States. Journal o f National Cancer Institute 73: 341-352.
91
